Annual Accounts Receivable
$13.12 M
+$1.01 M+8.38%
December 31, 2024
Summary
- As of March 13, 2025, LUNG annual accounts receivable is $13.12 million, with the most recent change of +$1.01 million (+8.38%) on December 31, 2024.
- During the last 3 years, LUNG annual accounts receivable has risen by +$6.56 million (+99.94%).
- LUNG annual accounts receivable is now at all-time high.
Performance
LUNG Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$13.12 M
+$1.45 M+12.43%
December 1, 2024
Summary
- As of March 13, 2025, LUNG quarterly accounts receivable is $13.12 million, with the most recent change of +$1.45 million (+12.43%) on December 1, 2024.
- Over the past year, LUNG quarterly accounts receivable has increased by +$1.45 million (+12.43%).
- LUNG quarterly accounts receivable is now at all-time high.
Performance
LUNG Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
LUNG Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.4% | +12.4% |
| 3 y3 years | +99.9% | +12.4% |
| 5 y5 years | +138.1% | +12.4% |
LUNG Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.9% | at high | +99.9% |
| 5 y | 5-year | at high | +210.3% | at high | +396.0% |
| alltime | all time | at high | +344.8% | at high | +396.0% |
Pulmonx Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $13.12 M(+8.4%) | - |
| Dec 2024 | - | $13.12 M(+12.4%) |
| Sep 2024 | - | $11.67 M(+5.3%) |
| Jun 2024 | - | $11.08 M(+5.3%) |
| Mar 2024 | - | $10.52 M(-13.1%) |
| Dec 2023 | $12.11 M(+39.5%) | $12.11 M(+20.0%) |
| Sep 2023 | - | $10.09 M(+12.9%) |
| Jun 2023 | - | $8.94 M(+9.4%) |
| Mar 2023 | - | $8.17 M(-5.8%) |
| Dec 2022 | $8.68 M | $8.68 M(+20.2%) |
| Sep 2022 | - | $7.22 M(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $7.52 M(+10.4%) |
| Mar 2022 | - | $6.81 M(+3.8%) |
| Dec 2021 | $6.56 M(+55.2%) | $6.56 M(-5.2%) |
| Sep 2021 | - | $6.92 M(+0.5%) |
| Jun 2021 | - | $6.88 M(+34.5%) |
| Mar 2021 | - | $5.12 M(+21.1%) |
| Dec 2020 | $4.23 M(-23.3%) | $4.23 M(-19.6%) |
| Sep 2020 | - | $5.26 M(+98.9%) |
| Jun 2020 | - | $2.65 M(-52.0%) |
| Dec 2019 | $5.51 M(+86.8%) | $5.51 M |
| Dec 2018 | $2.95 M | - |
FAQ
- What is Pulmonx annual accounts receivable?
- What is the all time high annual accounts receivable for Pulmonx?
- What is Pulmonx annual accounts receivable year-on-year change?
- What is Pulmonx quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Pulmonx?
- What is Pulmonx quarterly accounts receivable year-on-year change?
What is Pulmonx annual accounts receivable?
The current annual accounts receivable of LUNG is $13.12 M
What is the all time high annual accounts receivable for Pulmonx?
Pulmonx all-time high annual accounts receivable is $13.12 M
What is Pulmonx annual accounts receivable year-on-year change?
Over the past year, LUNG annual accounts receivable has changed by +$1.01 M (+8.38%)
What is Pulmonx quarterly accounts receivable?
The current quarterly accounts receivable of LUNG is $13.12 M
What is the all time high quarterly accounts receivable for Pulmonx?
Pulmonx all-time high quarterly accounts receivable is $13.12 M
What is Pulmonx quarterly accounts receivable year-on-year change?
Over the past year, LUNG quarterly accounts receivable has changed by +$1.45 M (+12.43%)